Toronto Dominion Bank trimmed its position in shares of MetLife, Inc. (NYSE:MET - Free Report) by 7.4% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 316,817 shares of the financial services provider's stock after selling 25,337 shares during the quarter. Toronto Dominion Bank's holdings in MetLife were worth $26,131,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also bought and sold shares of the company. Acadian Asset Management LLC grew its holdings in MetLife by 7,837.0% during the 2nd quarter. Acadian Asset Management LLC now owns 1,129,353 shares of the financial services provider's stock valued at $79,250,000 after purchasing an additional 1,115,124 shares during the last quarter. Zurich Insurance Group Ltd FI purchased a new position in shares of MetLife during the third quarter valued at approximately $91,771,000. Dimensional Fund Advisors LP grew its stake in shares of MetLife by 22.4% during the second quarter. Dimensional Fund Advisors LP now owns 5,396,274 shares of the financial services provider's stock valued at $378,799,000 after buying an additional 988,666 shares during the last quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. increased its stake in MetLife by 79.1% in the third quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 1,726,209 shares of the financial services provider's stock worth $142,378,000 after purchasing an additional 762,291 shares during the period. Finally, Jacobs Levy Equity Management Inc. increased its stake in MetLife by 256.6% in the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 948,223 shares of the financial services provider's stock worth $78,209,000 after buying an additional 682,333 shares during the period. Institutional investors own 89.81% of the company's stock.
MetLife Stock Performance
MetLife stock traded up $2.89 during trading hours on Thursday, hitting $83.22. 6,466,464 shares of the stock traded hands, compared to its average volume of 3,330,530. The firm's 50 day moving average price is $83.75 and its 200-day moving average price is $77.22. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. The stock has a market capitalization of $57.62 billion, a price-to-earnings ratio of 16.20, a P/E/G ratio of 0.78 and a beta of 1.06. MetLife, Inc. has a 1 year low of $64.61 and a 1 year high of $89.05.
MetLife Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Tuesday, November 5th will be issued a $0.545 dividend. The ex-dividend date of this dividend is Tuesday, November 5th. This represents a $2.18 annualized dividend and a yield of 2.62%. MetLife's dividend payout ratio (DPR) is presently 43.95%.
Wall Street Analyst Weigh In
Several analysts have recently weighed in on the stock. Piper Sandler lifted their price target on shares of MetLife from $85.00 to $92.00 and gave the company an "overweight" rating in a research note on Wednesday, October 2nd. TD Cowen upped their price target on shares of MetLife from $97.00 to $99.00 and gave the stock a "buy" rating in a research report on Wednesday, November 27th. Wells Fargo & Company increased their target price on MetLife from $92.00 to $93.00 and gave the company an "overweight" rating in a research report on Tuesday, November 5th. StockNews.com raised shares of MetLife from a "hold" rating to a "buy" rating in a research report on Monday, November 25th. Finally, Jefferies Financial Group boosted their price objective on shares of MetLife from $89.00 to $95.00 and gave the stock a "buy" rating in a research note on Friday, September 27th. Fourteen investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, MetLife currently has an average rating of "Buy" and a consensus price target of $88.62.
Read Our Latest Analysis on MetLife
About MetLife
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Stories
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.